• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便蛋白质组学:研究囊性纤维化患者肠道菌群失调和炎症的工具。

Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis.

机构信息

Ghent University, Department of Biochemistry and Microbiology, K.L. Ledeganckstraat 35, B-9000 Ghent, Belgium.

Ghent University, Department of Applied Mathematics, Computer Science and Statistics, Krijgslaan 281, B-9000 Ghent, Belgium.

出版信息

J Cyst Fibros. 2016 Mar;15(2):242-50. doi: 10.1016/j.jcf.2015.08.003. Epub 2015 Aug 30.

DOI:10.1016/j.jcf.2015.08.003
PMID:26330184
Abstract

BACKGROUND

Several microbial studies reported gut microbiota dysbiosis in patients with cystic fibrosis (CF). The functional consequences of this phenomenon are poorly understood. Faecal metaproteomics allows the quantitative analysis of host and microbial proteins to address functional changes resulting from this dysbiosis.

METHODS

We analysed faecal protein extracts from fifteen patients with CF that have pancreatic insufficiency and from their unaffected siblings by shotgun proteomics. Novel computational and statistical tools were introduced to evaluate changes in taxonomic composition and protein abundance.

RESULTS

Faecal protein extracts from patients with CF were dominated by host proteins involved in inflammation and mucus formation. Taxonomic analysis of the microbial proteins confirmed the strong reduction of butyrate reducers such as Faecalibacterium prausnitzii and increase of Enterobacteriaceae, Ruminococcus gnavus and Clostridia species.

CONCLUSION

Faecal metaproteomics provides insights in intestinal dysbiosis, inflammation in patients with CF and can be used to monitor different disease markers in parallel.

摘要

背景

一些微生物研究报告称囊性纤维化 (CF) 患者存在肠道微生物群落失调。但人们对这种现象的功能后果知之甚少。粪便宏蛋白质组学允许定量分析宿主和微生物蛋白质,以解决这种失调引起的功能变化。

方法

我们通过鸟枪法蛋白质组学分析了 15 名胰腺功能不全的 CF 患者及其未受影响的兄弟姐妹的粪便蛋白提取物。引入了新的计算和统计工具来评估分类组成和蛋白质丰度的变化。

结果

CF 患者的粪便蛋白提取物主要由参与炎症和粘液形成的宿主蛋白组成。微生物蛋白的分类分析证实,丁酸还原菌(如 Faecalibacterium prausnitzii)大量减少,肠杆菌科、Ruminococcus gnavus 和梭菌属的数量增加。

结论

粪便宏蛋白质组学提供了 CF 患者肠道失调、炎症的深入见解,并可用于同时监测不同的疾病标志物。

相似文献

1
Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis.粪便蛋白质组学:研究囊性纤维化患者肠道菌群失调和炎症的工具。
J Cyst Fibros. 2016 Mar;15(2):242-50. doi: 10.1016/j.jcf.2015.08.003. Epub 2015 Aug 30.
2
Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.双歧杆菌和梭状芽胞杆菌 XIVa 簇在囊性纤维化粪便微生物群中的失调。
J Cyst Fibros. 2013 May;12(3):206-15. doi: 10.1016/j.jcf.2012.10.003. Epub 2012 Nov 11.
3
A Method for Comprehensive Proteomic Analysis of Human Faecal Samples to Investigate Gut Dysbiosis in Patients with Cystic Fibrosis.一种全面的人粪便样本蛋白质组学分析方法,用于研究囊性纤维化患者的肠道菌群失调。
Adv Exp Med Biol. 2019;1073:137-160. doi: 10.1007/978-3-030-12298-0_6.
4
Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis.囊性纤维化患儿的肠道微生物群:分类和功能失调。
Sci Rep. 2019 Dec 9;9(1):18593. doi: 10.1038/s41598-019-55028-7.
5
Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.囊性纤维化中的肠道微生物组特征:宿主 CFTR 功能丧失导致微生物组肠病表型。
PLoS One. 2018 Dec 6;13(12):e0208171. doi: 10.1371/journal.pone.0208171. eCollection 2018.
6
Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.早期生命中肠道微生物组的发育:囊性纤维化和抗生素治疗的影响。
J Cyst Fibros. 2020 Jul;19(4):553-561. doi: 10.1016/j.jcf.2020.04.007. Epub 2020 May 30.
7
Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.肠道特异性 Cftr 敲除小鼠在预防肠梗阻方案下的粪便菌群失调和炎症。
Physiol Genomics. 2024 Mar 1;56(3):247-264. doi: 10.1152/physiolgenomics.00077.2023. Epub 2023 Dec 11.
8
Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis.一组成年囊性纤维化患者微量营养素摄入量与肠道微生物群之间的关联。
Clin Nutr. 2017 Aug;36(4):1097-1104. doi: 10.1016/j.clnu.2016.06.029. Epub 2016 Aug 27.
9
The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.囊性纤维化中的神秘肠道:炎症、微生物群失调与恶性肿瘤风险增加之间的联系
Curr Gastroenterol Rep. 2017 Feb;19(2):6. doi: 10.1007/s11894-017-0546-0.
10
Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis.囊性纤维化患儿胃肠道中分类群失调和功能失衡的宏基因组学证据。
Sci Rep. 2016 Mar 4;6:22493. doi: 10.1038/srep22493.

引用本文的文献

1
Human gut microbiota analysis of cystic fibrosis infants using metaproteomics.采用宏蛋白质组学对囊性纤维化婴儿的肠道微生物群进行分析。
Microbiol Resour Announc. 2024 Aug 13;13(8):e0005924. doi: 10.1128/mra.00059-24. Epub 2024 Jul 5.
2
Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.囊性纤维化患儿接受依伐卡托韦-泰他卡托韦-艾美卡替治疗后的肠道微生物组纵向分析。
mBio. 2024 Feb 14;15(2):e0193523. doi: 10.1128/mbio.01935-23. Epub 2024 Jan 26.
3
Development of the intestinal microbiome in cystic fibrosis in early life.
婴儿期囊性纤维化的肠道微生物组发育。
mSphere. 2023 Aug 24;8(4):e0004623. doi: 10.1128/msphere.00046-23. Epub 2023 Jul 5.
4
Fecal and Urinary Adipokines as Disease Biomarkers.粪便和尿液中的脂肪因子作为疾病生物标志物
Biomedicines. 2023 Apr 16;11(4):1186. doi: 10.3390/biomedicines11041186.
5
Current progress and critical challenges to overcome in the bioinformatics of mass spectrometry-based metaproteomics.基于质谱的宏蛋白质组学的生物信息学当前进展及需克服的关键挑战。
Comput Struct Biotechnol J. 2023 Jan 16;21:1140-1150. doi: 10.1016/j.csbj.2023.01.015. eCollection 2023.
6
Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?生物活性食物成分能否有助于预防囊性纤维化相关心血管疾病?
Nutrients. 2023 Jan 8;15(2):314. doi: 10.3390/nu15020314.
7
Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.囊性纤维化相关的肠道菌群失调:一项系统综述。
Dig Dis Sci. 2023 May;68(5):1797-1814. doi: 10.1007/s10620-022-07812-1. Epub 2023 Jan 4.
8
Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis.统计评估宏蛋白质组学和 16S rRNA 扩增子测序技术在研究囊性纤维化婴儿肠道微生物组建立中的应用。
Microbiol Spectr. 2022 Dec 21;10(6):e0146622. doi: 10.1128/spectrum.01466-22. Epub 2022 Oct 18.
9
The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps.来自土豆、香蕉和苹果纤维的抗性淀粉混合物对胃肠道和微生物群的影响:一项使用智能胶囊的随机临床试验
Front Nutr. 2022 Sep 29;9:987216. doi: 10.3389/fnut.2022.987216. eCollection 2022.
10
Bringing pharmacomicrobiomics to the clinic through well-designed studies.通过精心设计的研究将药物微生物组学引入临床。
Clin Transl Sci. 2022 Oct;15(10):2303-2315. doi: 10.1111/cts.13381. Epub 2022 Aug 9.